Health Care
UK Approves Pfizer/BioNTech Coronavirus Vaccine; Inoculation To Begin Next Week
The United Kingdom became the first country in the world to approve the highly-acclaimed Pfizer/BioNTech Coronavirus vaccine.
Setting the tone for mass inoculation, the new vaccine is reported to be 95 per cent effective in protecting people from COVID-19.
Read More: Top 5 Facts About Pfizer-BioNTech’s 90%-Effective COVID-19 Vaccine
As per the BBC, the MHRA – Britain’s medicine regulator – stated that the vaccine is 95 per cent effective, and that it is safe to be rolled out.
Eight hundred thousand doses are expected to be available in the UK from next week, and people will be contacted by the NHS for inoculation.
Priority will be given to the elderly, caregivers, and NHS staff – though a rounded priority list is expected to be released soon.
Pfizer had stated earlier in November that as much as 50 million vaccines would hit the global markets before the end of this year, while another 1.3 billion will be supplied to health professionals by 2021.
Named the BNT162b2, the mRNA-based vaccine was jointly developed by American pharmaceutical company Pfizer and German biotech company BioNTech.
Sources: BBC, Pfizer
-
Artificial Intelligence2 months agoTop 5 Interesting Things AI Did This Month – September 2026 Edition
-
Economy1 month agoOER Magazine September Edition 2026
-
Fashion1 month agoLuxury Watches That Could Appreciate Over the Next Decade [2026 Auction Buyer Guide]
-
Alamaliktistaad Magazines1 month agoAlam Al-Iktisaad Magazine September 2026 Edition
-
Banking & Finance2 months agoThe GCC’s 10 Richest Billionaires: Inside US$253.5 Billion of Wealth
-
Banking & Finance2 months agoINVESTIGATION: What If You Bought Apple Stock Every Time You Bought an iPhone?
-
News2 months agoOPEC+ Holds Output Steady for October as Focus Shifts to 2027 Quotas
-
Artificial Intelligence2 months agoWhat the World’s Top 10 Tech CEOs Really Earn
